UAE announces research partnership on Russian COVID-19 vaccine Sputnik V

  • Date: 26-Jan-2021
  • Source: Saudi Gazette
  • Sector:Healthcare
  • Country:UAE
  • Who else needs to know?

UAE announces research partnership on Russian COVID-19 vaccine Sputnik V

AL AIN, the United Arab Emirates — The United Arab Emirates University (UAEU) is supporting the clinical trial of the novel coronavirus (COVID-19) vaccine developed by the Gamaleya Institute of Epidemiology and Microbiology in Russia.

The vaccine is the world's first registered vaccine based on a well-studied human adenoviral vector-based platform. Sputnik V is nearing the end of the clinical testing process with 40,000 volunteers currently involved in a phase III trial in Russia. Interim results have shown the vaccine has 92 percent efficacy after the second dose.

Phase III trials have been announced in selected partner countries including the UAE, which has already recruited more than 500 volunteers.

The UAE trial is led by Dr. Ahmed Al Hammadi (Consultant in Infectious Diseases, Tawam Hospital) and supported by Dr. Basel Al Ramadi, Professor of Immunology and Chairman of the Department of Medical Microbiology and Immunology, College of Medicine & Health Sciences (CMHS), UAE University. Product Development Company (PDC) will be conducting the study in Al Ain with Pure Health managing the project. Volunteers in the